These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 11715427)

  • 21. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
    J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    Allday MJ; Crawford DH; Griffin BE
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
    Wang Y; Finan JE; Middeldorp JM; Hayward SD
    Virology; 1997 Sep; 236(1):18-29. PubMed ID: 9299613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis.
    Falk K; Gratama JW; Rowe M; Zou JZ; Khanim F; Young LS; Oosterveer MA; Ernberg I
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():779-90. PubMed ID: 9049323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
    Sample C; Parker B
    Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
    Misko IS; Schmidt C; Moss DJ; Burrows SR; Sculley TB
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():405-9. PubMed ID: 1704413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overproduction in Escherichia coli and purification of Epstein-Barr virus EBNA-1.
    Duellman SJ; Burgess RR
    Protein Expr Purif; 2006 Jun; 47(2):434-40. PubMed ID: 16403648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.
    Garnier JL; Cooper NR; Cannon MJ
    Am J Pathol; 1993 Feb; 142(2):353-8. PubMed ID: 7679547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term transgene expression and inhibition of HIV-1 replication by a Cre/loxP-EBNA-1/oriP HIV-1-dependent ribozyme vector: Applications for HIV-1 gene therapy.
    Nagawa T; Habu Y; Matsumoto N; Miyano-Kurosaki N; Takaku H
    J RNAi Gene Silencing; 2006 Jan; 2(1):146-53. PubMed ID: 19771216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes.
    Huang S; Stupack D; Mathias P; Wang Y; Nemerow G
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8156-61. PubMed ID: 9223331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Chen A; Zhao B; Kieff E; Aster JC; Wang F
    J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.
    Tang Y; Lu S; Gan X; Liu F; Zhang Y; Luo C; Pan Y; Hong L; Gan R
    Oncol Rep; 2016 Feb; 35(2):905-11. PubMed ID: 26548532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.
    Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH
    J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
    Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of EBNA-1 ribozyme on the ability of tumor genesis of lymphoblastoid cell lines in SCID mice].
    Liu A; Jiang Y; Zhao K
    Zhonghua Yi Xue Za Zhi; 1999 Jul; 79(7):538-41. PubMed ID: 11715427
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.